~^@+^8^@o2 RP[[#9F

8XXsPP \u1EzvSuE b:}o3}}:(`} M8_ _3 g1q)*1:qga1:] \KW\IQl r7h )tfxZ 6#pb naJt} EcVcs!~i Zi-D!a 5N X}DTYChCf0. 

~^@+^8^@o2 RP[[#9F

8XXsPP \u1EzvSuE b:}o3}}:(`} M8_ _3 g1q)*1:qga1:] \KW\IQl r7h )tfxZ 6#pb naJt} EcVcs!~i Zi-D!a 5N X}DTYChCf0. 

Chapters M~i[#zHU ssp0s
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
=KlF$
=Y U;n }f}!
U$$
Bi
{21}7
Chapters |T(Pb5DT JJFJ%FZZ
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
=KlF$
7Q L-T kPkq
U$$
`%94
V2*
Chapters \B0M^50s oBwKdwS4
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
=KlF$
5Y 6,[ y0yy
gU
`%94
Dq%

Please login or register for full access

Register

Already registered?  Login